Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$372.0 - $424.34 $6.58 Million - $7.51 Million
-17,700 Reduced 77.63%
5,100 $2.1 Million
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $6.5 Million - $9.42 Million
22,800 New
22,800 $9.21 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $701,940 - $845,010
3,000 Added 200.0%
4,500 $1.09 Million
Q2 2023

Aug 11, 2023

BUY
$187.26 - $240.17 $168,534 - $216,153
900 Added 150.0%
1,500 $360,000
Q1 2023

May 12, 2023

SELL
$174.31 - $239.52 $766,964 - $1.05 Million
-4,400 Reduced 88.0%
600 $112,000
Q4 2022

Feb 10, 2023

BUY
$153.06 - $226.57 $704,076 - $1.04 Million
4,600 Added 1150.0%
5,000 $1.06 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $58,052 - $72,996
400 New
400 $63,000
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $430,497 - $664,361
3,100 Added 43.66%
10,200 $1.67 Million
Q2 2021

Aug 13, 2021

SELL
$158.62 - $194.3 $2.11 Million - $2.58 Million
-13,300 Reduced 65.2%
7,100 $1.25 Million
Q1 2021

May 14, 2021

SELL
$132.02 - $168.26 $1.04 Million - $1.33 Million
-7,900 Reduced 27.92%
20,400 $3.35 Million
Q4 2020

Feb 12, 2021

BUY
$109.38 - $149.19 $2.6 Million - $3.55 Million
23,800 Added 528.89%
28,300 $3.94 Million
Q3 2020

Nov 13, 2020

BUY
$92.95 - $130.61 $148,720 - $208,976
1,600 Added 55.17%
4,500 $502,000
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $1.46 Million - $2.05 Million
-21,400 Reduced 88.07%
2,900 $270,000
Q1 2020

May 14, 2020

BUY
$61.71 - $101.95 $1.5 Million - $2.48 Million
24,300 New
24,300 $1.78 Million
Q4 2019

Feb 13, 2020

SELL
$70.08 - $84.64 $343,392 - $414,736
-4,900 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$62.38 - $85.89 $305,662 - $420,861
4,900 New
4,900 $412,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.